CHF145.75
0.34% today
SIX Swiss Exchange, Apr 25, 11:40 am CET
ISIN
CH0210483332
Symbol
CFR

Richemont Target price 2025 - Analyst rating & recommendation

Richemont Classifications & Recommendation:

Buy
53%
Hold
47%

Richemont Price Target

Target Price CHF167.04
Price CHF145.25
Potential 15.00%
Number of Estimates 27
27 Analysts have issued a price target Richemont 2026 . The average Richemont target price is CHF167.04. This is 15.00% higher than the current stock price. The highest price target is CHF210.76 45.10% , the lowest is CHF139.07 4.25% .
A rating was issued by 30 analysts: 16 Analysts recommend Richemont to buy, 14 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2026 of 15.00% . Most analysts recommend the Richemont stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029


Mar '24 2025
Estimates
Revenue Billion CHF 19.80 20.05
0.10% 1.24%
EBITDA Margin 30.52% 27.83%
5.56% 8.83%
Net Margin 11.64% 9.80%
7,788.05% 15.84%

27 Analysts have issued a sales forecast Richemont 2025 . The average Richemont sales estimate is CHF20.0b . This is 2.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.2b 8.16% , the lowest is CHF19.3b 1.41% .

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF19.8b 0.10%
2025 CHF20.0b 1.24%
2026 CHF21.2b 5.50%
2027 CHF22.6b 6.76%
2028 CHF23.7b 5.05%
2029 CHF25.2b 6.35%

24 Analysts have issued an Richemont EBITDA forecast 2025. The average Richemont EBITDA estimate is CHF5.6b . This is 1.28% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF6.0b 5.35% , the lowest is CHF4.6b 18.54% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CHF6.0b 5.65%
2025 CHF5.6b 7.69%
2026 CHF6.1b 9.30%
2027 CHF6.8b 10.70%
2028 CHF7.3b 7.56%

EBITDA Margin

2024 30.52% 5.56%
2025 27.83% 8.83%
2026 28.84% 3.63%
2027 29.90% 3.68%
2028 30.62% 2.41%

11 Richemont Analysts have issued a net profit forecast 2025. The average Richemont net profit estimate is CHF2.0b . This is 56.79% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF2.2b 77.47% , the lowest is CHF911m 27.26% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF2.3b 7,780.00%
2025 CHF2.0b 14.84%
2026 CHF3.7b 89.17%
2027 CHF4.2b 13.30%
2028 CHF4.7b 10.81%

Net Margin

2024 11.64% 7,788.05%
2025 9.80% 15.84%
2026 17.56% 79.18%
2027 18.64% 6.15%
2028 19.66% 5.47%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Mar '24 2025
Estimates
Earnings Per Share CHF 3.94 3.36
7,780.00% 14.72%
P/E 43.29
EV/Sales 4.16

11 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF3.36 . This is 57.01% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF3.80 77.57% , the lowest is CHF1.56 27.10% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF3.94 7,780.00%
2025 CHF3.36 14.72%
2026 CHF6.35 88.99%
2027 CHF7.19 13.23%
2028 CHF7.97 10.85%

P/E ratio

Current 67.90 46.46%
2025 43.29 36.24%
2026 22.88 47.15%
2027 20.20 11.71%
2028 18.23 9.75%

Based on analysts' sales estimates for 2025, the Richemont stock is valued at an EV/Sales of 4.16 and an P/S ratio of 4.24 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.26 1,604.00%
2025 4.16 2.35%
2026 3.94 5.21%
2027 3.69 6.33%
2028 3.52 4.81%
2029 3.31 5.97%

P/S ratio

Current 4.34 1,208.53%
2025 4.24 2.27%
2026 4.02 5.21%
2027 3.77 6.33%
2028 3.58 4.81%
2029 3.37 5.97%

Current Richemont Upgrades & Downgrades

Analyst Rating Action Date
JEFFERIES
Buy
Buy
Unchanged Apr 07 2025
BERENBERG
Hold
Hold
Unchanged Apr 07 2025
HSBC
Buy
Buy
Unchanged Mar 23 2025
ODDO BHF
Buy
Buy
Unchanged Mar 19 2025
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED
Neutral
Neutral
Unchanged Mar 19 2025
BANCO SANTANDER
Outperform
Outperform
Unchanged Mar 19 2025
TD COWEN
Hold
Buy
Upgrade Mar 17 2025
Analyst Rating Date
Unchanged
JEFFERIES:
Buy
Buy
Apr 07 2025
Unchanged
BERENBERG:
Hold
Hold
Apr 07 2025
Unchanged
HSBC:
Buy
Buy
Mar 23 2025
Unchanged
ODDO BHF:
Buy
Buy
Mar 19 2025
Unchanged
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED:
Neutral
Neutral
Mar 19 2025
Unchanged
BANCO SANTANDER:
Outperform
Outperform
Mar 19 2025
Upgrade
TD COWEN:
Hold
Buy
Mar 17 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today